This article has been updated to reflect that Orig3n did not acquire Interleukin's heart health test, which was previously sold. A press release announcing the acquisition inaccurately mentioned the test, according to an Orig3n spokesperson
NEW YORK (GenomeWeb) – Orig3n announced today that it has acquired Interleukin Genetics' CLIA-certified laboratory and its remaining assets.
Financial terms of the deal were not disclosed.